Workspace operator WeWork Cos is in talks with banks to raise $2.75 billion in d...
FILE PHOTO: The WeWork logo is displayed outside a co-working space in New York City, New York U.S., January 8, 2019. REUTERS/Brendan McDermid
- Workspace operator WeWork Cos is in talks with banks to raise $2.75 billion in debt ahead of its initial public offering, Bloomberg reported on Wednesday, citing people familiar with the matter.WeWork declined to comment, while JPMorgan did not immediately respond to a request for comment. The company is currently preparing for a stock market listing, which could be the largest IPO after ride-hailing firm Uber Technologies.
In April, WeWork filed confidentially with the U.S. Securities and Exchange Commission for an IPO and was last valued at about $47 billion in a series of private fundraisings.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Infrastructure Week dies — again"There wasn’t going to be a $2 trillion deal anyway," Republican Rep. Sam Graves said.
Weiterlesen »
Geoffrey Rush awarded $2 million in Sydney defamation caseOscar-winning actor Geoffrey Rush awarded $2 million in defamation case over reports he had been accused of inappropriate behavior toward an actress.
Weiterlesen »
This $2 app changed the way I work.NBCNewsBETTER: With the Pomodoro Technique, you pick a task, set a timer for 25 minutes to work on that one thing, take a 5-minute break when the timer rings and repeat.
Weiterlesen »
Gene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
Weiterlesen »
U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therap...
Weiterlesen »
Novartis $2 million gene therapy for rare disorder is world's most expensive drugSwiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA) and priced the one-time treatment at a record $2.125 million
Weiterlesen »
At $2 Million, New Novartis Drug Is Priciest EverNovartis said it plans to price its recently approved gene therapy at $2.125 million, making it the world’s most expensive medicine.
Weiterlesen »
Autonomous taxis will become a $2 trillion market, UBS saysThe global autonomous taxi market could be worth over $2 trillion on an annual basis by 2030, according to estimates from UBS analysts.
Weiterlesen »
The Swiss Surfer Behind $2 Billion Payments Startup Checkout.comGuillaume Pousaz has built a payments firm he acquired in 2009 into a highly valued transaction processor for fast-growing internet companies that is now expanding in the U.S. and moving into other financial services.
Weiterlesen »
'Jeopardy!' champion James Holzhauer passes $2 million markThe 34-year-old professional sports gambler from Las Vegas went into Final Jeopardy with a lead of more than $30,000 and was the only contestant who answered the 'Around the USA' clue
Weiterlesen »